$1.69 +0.01 (0.60%) Cleveland Biolabs Inc - NASDAQ

Sep. 27, 2016 | 03:46 PM
Last Trade: 1.69
Trade Time: Sep 27 03:46 PM Eastern Daylight Time
Change: +0.01 (0.60%)
Prev Close: 1.68
Open: 1.68
Bid: 1.66
Ask: 1.69
  1. No results found.
  1. Entolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T ...

    GuruFocus | Feb. 9, 2016 | 23:02PM EST
  2. Cleveland BioLabs Announces Start of Phase 2 Study of CBLB612 in Russian Federation

    GuruFocus | Jan. 26, 2016 | 23:05PM EST
  3. Cleveland BioLabs Attains Orphan Drug Status From the EMA for Entolimod as a Radiation ...

    GuruFocus | Jan. 21, 2016 | 23:04PM EST
  4. Cleveland BioLabs and Rusnano Make Additional Investments in Panacela

    GuruFocus | Dec. 22, 2015 | 23:03PM EST
  5. Entolimod Shown to Suppress Liver Metastases in Model of Ocular Melanoma in Collaborative Study ...

    GuruFocus | Dec. 14, 2015 | 23:04PM EST
  6. Cleveland BioLabs Announces Expanded U.S. Patent Protection for Entolimod

    Benzinga | Nov. 30, 2015 | 07:30AM EST
  7. Cleveland BioLabs to Report Third Quarter 2015 Financial Results on November 5

    GuruFocus | Oct. 28, 2015 | 00:04AM EST
  8. Department of Defense Grants Cleveland BioLabs Second Award for Advanced Development of Entolimod as a Medical Radiation Countermeasure

    Benzinga | Sep. 21, 2015 | 07:30AM EST
  9. Cleveland BioLabs Announces Publication of Studies Demonstrating Efficacy of Entolimod as a ...

    GuruFocus | Sep. 17, 2015 | 00:03AM EST
  10. Cleveland BioLabs Reports Publication of Studies Showing Efficacy of Entolimod as Radiation Countermeasure

    Benzinga | Sep. 16, 2015 | 08:03AM EST
  11. Cleveland BioLabs to Present at Rodman & Renshaw 17th Annual Global Investment Conference

    GuruFocus | Sep. 3, 2015 | 00:03AM EST
  12. UPDATE: Cleveland Biolabs Awarded DoD Contract Up To $9.2M

    Benzinga | Sep. 2, 2015 | 11:52AM EST
  13. Cleveland BioLabs Announces New Patents Strengthening Entolimod Portfolio

    GuruFocus | Aug. 19, 2015 | 00:03AM EST
  14. Morning Market Losers

    Benzinga | Aug. 12, 2015 | 09:54AM EST
  15. Cleveland BioLabs Announces Date Change for Second Quarter 2015 Financial Results

    GuruFocus | Aug. 1, 2015 | 00:02AM EST
Trading Center